Same-day pancreatic clinics nearly double survival for metastatic patients

Same-day pancreatic multidisciplinary clinics (PMDC) significantly enhance care for metastatic pancreatic cancer patients. This approach increases rates of genetic testing, access to palliative services, and timely treatment initiation. Notably, PMDC patients survived an average of 487 days compared to 267 days for those receiving standard care. Improved enrollment in clinical trials further highlights PMDC’s role in advancing treatment timelines and outcomes, demonstrating a clear model for better management of this aggressive cancer.